197 related articles for article (PubMed ID: 30940907)
1. Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome.
Bono E; McLornan D; Travaglino E; Gandhi S; Gallì A; Khan AA; Kulasekararaj AG; Boveri E; Raj K; Elena C; Ireland RM; Bianchessi A; Jiang J; Todisco G; Ferretti VV; Cazzola M; Marsh JCW; Malcovati L; Mufti GJ
Leukemia; 2019 Oct; 33(10):2495-2505. PubMed ID: 30940907
[TBL] [Abstract][Full Text] [Related]
2. Hypocellular myelodysplastic syndromes (MDS): new proposals.
Tuzuner N; Cox C; Rowe JM; Watrous D; Bennett JM
Br J Haematol; 1995 Nov; 91(3):612-7. PubMed ID: 8555063
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
5. Hypoplastic form of myelodysplastic neoplasm.
Votavová H; Lenertová Z; Votava T; Beličková M
Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
[TBL] [Abstract][Full Text] [Related]
6. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.
Huang TC; Ko BS; Tang JL; Hsu C; Chen CY; Tsay W; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
Leukemia; 2008 Mar; 22(3):544-50. PubMed ID: 18094713
[TBL] [Abstract][Full Text] [Related]
7. Hypocellular myelodysplastic syndromes: clinical and biological significance.
Marisavljevic D; Cemerikic V; Rolovic Z; Boskovic D; Colovic M
Med Oncol; 2005; 22(2):169-75. PubMed ID: 15965280
[TBL] [Abstract][Full Text] [Related]
8. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
9. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
Varma N; Varma S; Marwaha N; Garewal G
Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
[TBL] [Abstract][Full Text] [Related]
10. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
[TBL] [Abstract][Full Text] [Related]
11. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
13. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
15. Hypoplastic myelodysplastic syndrome.
Nand S; Godwin JE
Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
[TBL] [Abstract][Full Text] [Related]
16. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.
Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS
Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376
[TBL] [Abstract][Full Text] [Related]
17. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.
Yue G; Hao S; Fadare O; Baker S; Pozdnyakova O; Galili N; Woda BA; Raza A; Wang SA
Leuk Res; 2008 Apr; 32(4):553-8. PubMed ID: 17888511
[TBL] [Abstract][Full Text] [Related]
18. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
Koh Y; Lee HR; Song EY; Kim HK; Kim I; Park S; Park MH; Kim BK; Yoon SS; Lee DS
Leuk Res; 2010 Oct; 34(10):1344-50. PubMed ID: 20427085
[TBL] [Abstract][Full Text] [Related]
19. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).
Yao CY; Hou HA; Lin TY; Lin CC; Chou WC; Tseng MH; Chiang YC; Liu MC; Liu CW; Kuo YY; Wu SJ; Liao XW; Lin CT; Ko BS; Chen CY; Hsu SC; Li CC; Huang SY; Yao M; Tang JL; Tsay W; Liu CY; Tien HF
Oncotarget; 2016 Sep; 7(39):63177-63188. PubMed ID: 27527853
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
